Nomura Holdings Inc Neoleukin Therapeutics, Inc. Transaction History

Nomura Holdings Inc

  • $41.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.92 - $2.25 $686 - $1,678
746 Added 4.81%
16,246 $16,000
Q1 2022

May 18, 2022
BUY
$1.72 - $5.23 $435 - $1,323
253 Added 1.66%
15,500 $29,000
Q4 2021

Feb 14, 2022
SELL
$4.65 - $7.75 $1,176 - $1,960
-253 Reduced 1.63%
15,247 $74,000
Q4 2020

Feb 16, 2021
BUY
$10.17 - $14.56 $157,635 - $225,680
15,500 New
15,500 $221,000

Others Institutions Holding NLTX

# of Institutions
1
Shares Held
199K
Call Options Held
0
Put Options Held
0
View Full List

About Neoleukin Therapeutics, Inc.

NLTX Quotes by TradingView
  • Ticker NLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,579,900
  • Description
  • Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...
More about NLTX
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email